Total Payments
$47,542
2024 Payments
$4,859
Companies
62
Transactions
1,048
Medicare Patients
13,193
Medicare Billing
$1.0M
Payment Breakdown by Category
Research$24,420 (51.4%)
Food & Beverage$21,149 (44.5%)
Travel$1,345 (2.8%)
Education$615.18 (1.3%)
Other$12.48 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $24,420 | 6 | 51.4% |
| Food and Beverage | $21,149 | 1,021 | 44.5% |
| Travel and Lodging | $1,345 | 5 | 2.8% |
| Education | $615.18 | 15 | 1.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12.48 | 1 | 0.0% |
Payments by Type
Research
$24,420
6 transactions
General
$23,122
1,042 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $25,607 | 66 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $2,583 | 125 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,056 | 103 | $0 (2024) |
| Amgen Inc. | $1,674 | 55 | $0 (2024) |
| Medtronic, Inc. | $1,671 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,284 | 79 | $0 (2024) |
| Novo Nordisk Inc | $1,253 | 71 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,233 | 57 | $0 (2024) |
| Lilly USA, LLC | $1,056 | 73 | $0 (2024) |
| Abbott Laboratories | $878.35 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,859 | 146 | Medtronic, Inc. ($916.78) |
| 2023 | $3,242 | 133 | Boehringer Ingelheim Pharmaceuticals, Inc. ($361.38) |
| 2022 | $3,353 | 140 | Medtronic, Inc. ($727.67) |
| 2021 | $2,117 | 98 | Boehringer Ingelheim Pharmaceuticals, Inc. ($326.85) |
| 2020 | $982.73 | 46 | AstraZeneca Pharmaceuticals LP ($318.31) |
| 2019 | $3,014 | 166 | AstraZeneca Pharmaceuticals LP ($445.57) |
| 2018 | $9,341 | 164 | SANOFI-AVENTIS U.S. LLC ($6,743) |
| 2017 | $20,634 | 155 | SANOFI-AVENTIS U.S. LLC ($18,478) |
All Payment Transactions
1,048 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.33 | General |
| 12/17/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Biological | ||||||
| 12/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Oncology | ||||||
| 12/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: VACCINES | ||||||
| 12/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Diabetes | ||||||
| 11/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Neurology | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.75 | General |
| 11/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $124.73 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $117.21 | General |
| Category: Diabetes Care | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $4.43 | General |
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Gastroenterology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Toujeo Real World Insulin Nai | SANOFI-AVENTIS U.S. LLC | $24,420 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 3,503 | 5,227 | $634,545 | $288,294 |
| 2022 | 27 | 3,506 | 4,842 | $600,256 | $287,869 |
| 2021 | 32 | 3,379 | 4,802 | $708,079 | $246,391 |
| 2020 | 29 | 2,805 | 4,292 | $553,490 | $206,799 |
Total Patients
13,193
Total Services
19,163
Medicare Billing
$1.0M
Procedure Codes
117
All Medicare Procedures & Services
117 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 369 | 796 | $159,200 | $76,858 | 48.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 245 | 245 | $61,250 | $36,500 | 59.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 301 | 822 | $82,200 | $36,134 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 195 | 328 | $57,400 | $24,991 | 43.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 279 | 281 | $56,200 | $24,683 | 43.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 176 | 181 | $36,200 | $13,644 | 37.7% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 284 | 284 | $21,300 | $8,554 | 40.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 230 | 236 | $11,800 | $8,491 | 72.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 377 | 906 | $18,120 | $7,594 | 41.9% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 83 | 87 | $21,750 | $6,444 | 29.6% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 23 | 23 | $6,850 | $5,721 | 83.5% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 49 | 49 | $19,600 | $5,287 | 27.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 237 | 237 | $8,295 | $5,112 | 61.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 25 | 25 | $7,500 | $4,768 | 63.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 21 | 21 | $8,400 | $3,518 | 41.9% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 39 | 39 | $7,800 | $3,057 | 39.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 240 | 255 | $15,300 | $3,046 | 19.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $4,200 | $2,676 | 63.7% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 17 | 20 | $4,000 | $1,878 | 46.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 14 | 14 | $2,800 | $1,831 | 65.4% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 56 | 56 | $5,600 | $1,775 | 31.7% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2023 | 20 | 24 | $3,600 | $1,651 | 45.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 38 | 40 | $2,000 | $1,439 | 72.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 40 | 75 | $4,500 | $983.25 | 21.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 17 | 21 | $2,100 | $965.80 | 46.0% |
About Dr. Thomas Mathew, MD
Dr. Thomas Mathew, MD is a Internal Medicine healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245282136.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Mathew, MD has received a total of $47,542 in payments from pharmaceutical and medical device companies, with $4,859 received in 2024. These payments were reported across 1,048 transactions from 62 companies. The most common payment nature is "" ($24,420).
As a Medicare-enrolled provider, Mathew has provided services to 13,193 Medicare beneficiaries, totaling 19,163 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 117 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Emergency Medicine
- Location New Hyde Park, NY
- Active Since 05/17/2006
- Last Updated 09/24/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1245282136
Products in Payments
- TOUJEO (Drug) $24,729
- FARXIGA (Drug) $1,640
- JARDIANCE (Drug) $1,621
- MINIMED 780G (Device) $943.37
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $727.67
- FREESTYLE LIBRE 3 (Device) $678.82
- INVOKANA (Drug) $623.99
- XARELTO (Drug) $602.59
- TRELEGY ELLIPTA (Drug) $584.20
- SOLIQUA (Drug) $477.90
- Kerendia (Drug) $439.35
- Otezla (Drug) $428.65
- JANUVIA (Drug) $399.02
- Vascepa (Drug) $395.70
- LOKELMA (Drug) $371.26
- TRULICITY (Drug) $334.61
- UNITHROID (Drug) $329.76
- LEQVIO (Drug) $325.65
- ANORO (Drug) $325.41
- Cologuard Collection Kit (Device) $304.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New Hyde Park
Dr. Michael Levine, Md, MD
Internal Medicine — Payments: $394,059
Internal Medicine $394,059
Nikhil Sharma, M.d, M.D
Internal Medicine — Payments: $89,735
Internal Medicine $89,735
Nagashree Seetharamu, Md, MD
Internal Medicine — Payments: $65,767
Internal Medicine $65,767
Dr. Abhinav Agrawal, M.d, M.D
Internal Medicine — Payments: $49,576
Internal Medicine $49,576
Dr. Kennedy Omonuwa, M.d, M.D
Internal Medicine — Payments: $45,556
Internal Medicine $45,556
Lydia Gorski, M.d, M.D
Internal Medicine — Payments: $21,738
Internal Medicine $21,738